Decoy Therapeutics Inc.
DCOY | NASDAQ
$1.03
-$0.04 (-3.74%)
Nov 2, 2026, 1:36 PM ET · Market open
Market Data
Market Cap $547.93K
Enterprise Value $-7.72M
Beta 0.58
Average Volume 1.7M
Shares Outstanding (Diluted) 531.97K
Shares Change YoY 275.89%
Institutional Ownership 0.81%
Exchange NASDAQ
ISIN US79400X6022
Price Performance
Price Change 1M -41.8%
Price Change 3M -76.3%
Price Change 6M -82.5%
Price Change YTD -86.8%
Price Change 1Y -97.6%
Price Change 3Y -99.9%
Price Change 5Y -100.0%
1M CAGR (ann.) -61.5%
1Y CAGR (ann.) -97.7%
5Y CAGR (ann.) -87.2%
All-Time CAGR -78.4%
Valuation
PE Ratio -0.04
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.00
PS Ratio N/A
Forward PS N/A
PB Ratio 0.13
P/FCF Ratio -0.07
P/Adj. FCF Ratio -0.06
P/OCF Ratio -0.07
EV/Sales N/A
EV/EBIT 0.53
EV/EBITDA 0.53
EV/FCF 0.92
Earnings Yield -2718.7%
FCF Yield -1469.9%
Adj. FCF Yield -1547.6%
Financial Health
Net Cash $8.29M
Total Debt $0
Cash & Short-Term Investments $8.29M
Total Assets $9M
Current Ratio 1.83
Quick Ratio 1.83
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -20.11
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -5.3%
Returns
Return on Assets -160.5%
Return on Equity -315.2%
Return on Invested Capital -343.6%
Return on Capital Employed -343.6%
Return on Tangible Assets -160.5%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y 100.0%
Revenue CAGR 10Y -25.9%
EPS CAGR 3Y 90.0%
EPS CAGR 5Y 63.5%
EPS CAGR 10Y 38.5%
FCF CAGR 3Y -5.0%
FCF CAGR 5Y 22.5%
FCF CAGR 10Y 15.1%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 13, 2026
EPS Estimate (next Q) -$2.59
EPS Growth Est (next Q) 43.1%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $-8.32M
Free Cash Flow $-8.37M
Adj. Free Cash Flow $-8.81M
FCF Per Share -$15.73
OCF Per Share -$15.65
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-8.52M
Operating Income $-14.84M
EBITDA $-14.44M
Net Income $-14.45M
EPS (Diluted) -$29.09
Revenue / Employee N/A
Profit / Employee $-1.31M
Employees 11
Add to Watchlist
Select watchlists to add or remove DCOY